Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA

OBJECTIVE: To compare the risk of lupus-like events (LLEs) and vasculitis-like events (VLEs) in tumour necrosis factor-α inhibitor (TNFi)-treated patients with rheumatoid arthritis (RA) to those receiving non-biological disease-modifying antirheumatic drugs (nbDMARDs). METHODS: Patients were recruit...

Descripción completa

Detalles Bibliográficos
Autores principales: Jani, Meghna, Dixon, William G, Kersley-Fleet, Lianne, Bruce, Ian N, Chinoy, Hector, Barton, Anne, Lunt, Mark, Watson, Kath, Symmons, Deborah P, Hyrich, Kimme L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5255894/
https://www.ncbi.nlm.nih.gov/pubmed/28123776
http://dx.doi.org/10.1136/rmdopen-2016-000314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5255894/
https://www.ncbi.nlm.nih.gov/pubmed/28123776
http://dx.doi.org/10.1136/rmdopen-2016-000314

Ejemplares similares